News from canntab therapeutics limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 03, 2021, 07:34 ET Canntab Announces the Early Exercise of $1,259,250 Warrants

TORONTO, June 3, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Mar 30, 2021, 07:30 ET Canntab Receives Export License Approval from Health Canada

TORONTO, March 30, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a...

Mar 09, 2021, 00:05 ET Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

3rd Patent Grant with Australia following the United States and Canada Initial Australian Purchase Order of $406,200 from our Australian partner Cann ...

Feb 01, 2021, 09:27 ET Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets

TORONTO, Feb. 1, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading ...

Dec 01, 2020, 08:30 ET Canntab Begins Delivery of Tablets to MediPharm

TORONTO, Dec. 1, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Oct 26, 2020, 00:53 ET Canntab to Launch in Australia and Participate in Australia's Largest Cannabis Research Study

TORONTO, Oct. 26, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Sep 21, 2020, 09:14 ET Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets

TORONTO, Sept. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Aug 21, 2020, 08:56 ET Canntab announces planned purchases of cannabis processing equipment and leasehold improvements

TORONTO, Aug. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Aug 19, 2020, 07:30 ET Canntab Appoints Larry Latowsky as CEO

TORONTO, Aug. 19, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...

Jun 02, 2020, 10:41 ET Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement

TORONTO, June 2, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

May 15, 2020, 07:30 ET Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer

TORONTO, May 15, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

May 11, 2020, 07:30 ET Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference

TORONTO, May 11, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Mar 16, 2020, 07:30 ET Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m

TORONTO, March 16, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading ...

Mar 06, 2020, 08:00 ET Canntab Announces Replacement of Advisor Warrants and Intention to Appoint Larry Latowsky as Director and Executive Chairman of the Board

TORONTO, March 6, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Mar 02, 2020, 09:15 ET Canntab Receives Health Canada Licence and Closes $3.08M Offering

Receives its Cannabis Standard Processing & Sales for Medical Purposes Licence Closes first tranche of its non-brokered private placement for gross...

Feb 24, 2020, 07:30 ET Canntab Awarded Health Canada Cannabis Research Licence

TORONTO, Feb. 24, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Feb 06, 2020, 13:38 ET Canntab Announces Non-Brokered Private Placement

TORONTO, Feb. 6, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Dec 23, 2019, 02:30 ET Canntab Submits Site Evidence Package to Health Canada to Obtain LP Status

The final step to obtain a licence to process Canntab's cannabis hard pill formulation, at its fully built out Markham, Ontario facility. Retains...

Nov 20, 2019, 12:15 ET Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States

Canntab will manufacture its hard pill formulations (made from CBD and other hemp derivatives) in a Florida facility operated by Exactus, using...

Oct 08, 2019, 11:29 ET Canntab to utilize the advanced BOSS extraction system from World Class Extractions to further its own extraction capabilities

TORONTO, Oct. 8, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Oct 08, 2019, 07:30 ET Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities

TORONTO, Oct. 8, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...

Aug 15, 2019, 07:00 ET Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation

TORONTO, Aug. 15, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading ...

Jul 31, 2019, 06:30 ET Canntab provides corporate update

Commercial batch manufacturing of oil-filled gel capsules to begin in Cobourg, leading to a Health Canada request for authorization to begin full...

May 30, 2019, 11:54 ET Canntab signs term sheet with Heritage for processing hemp for sale of CBD filled gelcaps

- Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 - TORONTO, May 30, 2019 /PRNewswire/ - Canntab Therapeutics Limited...

May 21, 2019, 07:30 ET Canntab Receives Cultivation Licence for Industrial Hemp

Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD)...